Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN

Oncogene
S PianettiG E Sonenshein

Abstract

The Nuclear Factor (NF)-kappaB family of transcription factors controls expression of genes which promote cell growth, survival, and neoplastic transformation. Recently we demonstrated aberrant constitutive activation of NF-kappaB in primary human and rat breast cancer specimens and in cell lines. Overexpression of the epidermal growth factor receptor (EGFR) family member Her-2/neu, seen in approximately 30% of breast cancers, is associated with poor prognosis. Previously, Her-2/neu has been shown to signal via a phosphatidylinositol 3 (PI3)-kinase to Akt/protein kinase B (PKB) pathway. Since this signaling pathway was recently shown to activate NF-kappaB, here we have tested the hypothesis that Her-2/neu can activate NF-kappaB in breast cancer. Overexpression of Her-2/neu and EGFR-4 in Ba/F3 cells led to constitutive PI3- and Akt kinase activities, and induction of classical NF-kappaB (p50/p65). Similarly, a tumor cell line and tumors derived from MMTV-Her-2/neu transgenic mice displayed elevated levels of classical NF-kappaB. Engagement of Her-2/neu receptor downregulated the level of NF-kappaB. NF-kappaB binding and activity in the cultured cells was reduced upon inhibition of the PI3- to Akt kinase signaling pathway via ect...Continue Reading

References

Mar 1, 1978·British Journal of Haematology·G SchiliròG Russo
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C T GuyW J Muller
Sep 1, 1992·The Journal of Experimental Medicine·D J KesslerG E Sonenshein
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D W BallardW C Greene
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M P DuyaoG E Sonenshein
Nov 1, 1983·Quarterly Reviews of Biophysics·S W Englander, N R Kallenbach
Nov 1, 1984·European Journal of Cancer & Clinical Oncology·H M KantarjianR G Martin
Sep 1, 1995·British Journal of Urology·S FossaP Selby
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M DolwickC A Bradfield
Mar 15, 1997·Genes & Development·S G KennedyN Hay
Jul 25, 1997·Cell·C H RégnierM Rothe
Jun 1, 1997·Postgraduate Medical Journal·M ZakiA Nour el Din
Jan 31, 1998·The Journal of Clinical Investigation·M A SovakG E Sonenshein
Jan 7, 1998·Molecular and Cellular Biology·S MiyamotoS D Shumway
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y E WhangC L Sawyers
Jul 23, 1998·Bone Marrow Transplantation·S D RowleyW I Bensinger
Aug 11, 1998·Nature Genetics·A Di CristofanoP P Pandolfi
Oct 3, 1998·Bone Marrow Transplantation·J R ArgüelloJ A Madrigal
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·C BéraudP A Baeuerle
Apr 21, 1999·Current Opinion in Cell Biology·F Mercurio, A M Manning

❮ Previous
Next ❯

Citations

Aug 6, 2011·Archives of Toxicology·Todd L WattersonRoger A Coulombe
Oct 14, 2009·Molecular and Cellular Biochemistry·Sahdeo PrasadBharat B Aggarwal
May 16, 2002·Current Rheumatology Reports·Ulf Müller-LadnerSteffen Gay
Apr 22, 2011·Nature Reviews. Cancer·Sarah J StorrStewart G Martin
Nov 3, 2010·Oncogene·R R Shen, W C Hahn
Dec 21, 2010·Oncogene·M M ChaturvediB B Aggarwal
Feb 18, 2006·Cell Death and Differentiation·H J KimA S Baldwin
Apr 3, 2010·The Journal of Biological Chemistry·Allison S Limpert, Bruce D Carter
Nov 3, 2005·Toxicologic Pathology·Nicolas CurrierDavid C Seldin
Dec 17, 2005·Antioxidants & Redox Signaling·Amit K GargBharat B Aggarwal
May 24, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Nataša Todorović-Raković, Jelena Milovanović
Jul 19, 2013·Molecular Biology of the Cell·Marcio FonteneleHelena Araujo
Jun 6, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gary L WrightRobin C Muise-Helmericks
Jan 22, 2002·Current Opinion in Obstetrics & Gynecology·Eleanor Latta, William B Chapman
Jan 23, 2008·Photochemistry and Photobiology·Neehar BhatiaVladimir S Spiegelman
Dec 12, 2001·Molecular and Cellular Biology·N O CarragherM C Frame
Aug 5, 2003·Molecular and Cellular Biology·Raphaëlle Romieu-MourezGail E Sonenshein
Mar 18, 2003·Molecular and Cellular Biology·Sébastien JeayGail E Sonenshein
Feb 4, 2010·Cancer Research·Yiwei LiFazlul H Sarkar
Apr 24, 2010·Oncology·Soham D PuvvadaBert H O'Neil
Aug 28, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xiaojun LiHong Ren
Jun 27, 2009·American Journal of Respiratory Cell and Molecular Biology·Rachel KettleCarol E Jones
Nov 27, 2007·The Journal of Clinical Investigation·Karine Belguise, Gail E Sonenshein
Mar 28, 2009·International Journal of Molecular Sciences·Masahito ShimizuHisataka Moriwaki
Aug 31, 2013·Journal of Cancer Research and Clinical Oncology·Nadire DuruJian Jian Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.